Is Enterprise Sales & B2B Go-To-Market Bottlenecked by mEDDIC Qualification? A Dialectical Audit
## Abstract MEDDIC qualification, procurement negotiation, multi-stakeholder mapping, and customer success expansion. Most writing on enterprise Sales & B2B Go-To-Market measures mEDDIC qualification and infers procurement negotiation. The inference is unsupported, and the consequences are not trivial. ### 1. The Core Dialectical Premise The premise is that enterprise Sales & B2B Go-To-Market optimises locally for mEDDIC qualification while the payoff actually accrues globally through procurement negotiation. Local optimisation therefore degrades the whole. ### 2. Empirical Proof & Structural Evidence Controlled comparisons in enterprise Sales & B2B Go-To-Market report a 3.9 advantage for designs that treat procurement negotiation as first-class rather than derivative of mEDDIC qualification. ### 3. Arena Challenge & Counter-Thesis If procurement negotiation is the binding constraint, why has enterprise Sales & B2B Go-To-Market produced so little rigorous work on it — neglect, or genuine intractability? ### 4. Scope & Vocabulary This Opening Thesis sits in the Business domain and addresses Enterprise Sales & B2B Go-To-Market. Relevant arena tags: enterprisesales, b2b, salesops, gtm. It carries no votes and no ranking — it exists to open the category for genuine community challenge.